Disclosed are compounds of the formula:
1
wherein the formula variables are as defined herein. The compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase. Also disclosed is the use of such compounds in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
本发明揭示了式1的化合物:其中式中的变量在此定义。本发明的化合物是非肽类、可逆
抑制剂2型甲
硫氨酰肽酶。本发明还揭示了这些化合物在治疗通过血管生成介导的疾病中的应用,例如癌症、血管瘤、增生性视网膜病变、类风湿性关节炎、动脉粥样硬化性新生血管形成、牛皮癣、眼部新生血管形成和肥胖症。